Latest news
{{'2026-07-31T11:21:00Z' | dateFormatFilter}}
Novo Nordisk provides update on the ZEUS phase 3 trial in people with ASCVD, CKD and inflammation
{{'2026-07-21T11:35:00Z' | dateFormatFilter}}
Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly
{{'2026-07-15T15:51:00Z' | dateFormatFilter}}
Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved
Investors
Share price
{{priceData.date}} {{priceData.time}}
{{priceData.currentPrice}}
{{priceData.currency}}
Go to stock watch
{{priceData.change}} {{priceData.currency}}
